Structure-based de novo design, synthesis, and biological evaluation of the indole-based PPARγ ligands (I)

被引：12
|
作者：
Dong, Xiaochun
Zhang, Zhenshan
Wen, Ren [1 ]
Shen, Jianhua
Shen, Xu
Jiang, Hualiang
机构：
[1] Fudan Univ, Dept Med Chem, Shanghai 200032, Peoples R China
[2] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2006年 / 16卷 / 22期
关键词：
de novo drug design; PPAR gamma ligand; type II diabetes; indole compounds;
D O I：
10.1016/j.bmcl.2006.06.093
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
MCSS and LeapFrog, two de novo drug design programs, were used for the novel indole-based PPAR gamma ligands' study. The designed compounds were synthesized and tested for the PPAR gamma protein binding activities in vitro. Out of the compounds that were synthesized, two molecules (compounds 14d and 7d) possessed potent PPAR gamma protein binding activity close to rosiglitazone in vitro. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码：5913 / 5916
页数：4
相关论文
共 50 条
  • [41] De Novo Structure-Based Design of Bis-amidoxime Uranophiles
    Vukovic, Sinisa
    Hay, Benjamin P.
    INORGANIC CHEMISTRY, 2013, 52 (13) : 7805 - 7810
  • [42] ENPDA: an evolutionary structure-based de novo peptide design algorithm
    Ignasi Belda
    Sergio Madurga
    Xavier Llorà
    Marc Martinell
    Teresa Tarragó
    Mireia G. Piqueras
    Ernesto Nicolás
    Ernest Giralt
    Journal of Computer-Aided Molecular Design, 2005, 19 : 585 - 601
  • [43] Role for chemoinformatics in structure-based de novo ligand design.
    Johnson, AP
    Boda, K
    Lengyel, T
    Weaver, S
    Vigh, A
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U363 - U363
  • [44] Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A
    Guichou, JF
    Viaud, J
    Mettling, C
    Subra, G
    Lin, YL
    Chavanieu, A
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (03) : 900 - 910
  • [45] Structure-based discovery of potent inhibitors of Axl: design, synthesis, and biological evaluation
    Wu, Shuang
    Liao, Min
    Li, Minxiong
    Sun, Mingming
    Xi, Ning
    Zeng, Youlin
    RSC MEDICINAL CHEMISTRY, 2022, 13 (10): : 1246 - 1264
  • [46] De novo drug design:: Integration of structure-based and ligand-based methods
    Dean, PM
    Lloyd, DG
    Todorov, NP
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (03) : 347 - 353
  • [47] Structure-based design of opioid ligands
    Ferguson, David M.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [48] Synthesis, biological evaluation, and molecular docking investigation of benzhydrol- and indole-based dual PPAR-γ/FFAR1 agonists
    Darwish, Khaled M.
    Salama, Ismail
    Mostafa, Samia
    Gomaa, Mohamed S.
    Khafagy, El-Sayed
    Helal, Mohamed A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1595 - 1602
  • [49] Generation and selection of novel estrogen receptor ligands using the de novo structure-based design tool, SkelGen
    Firth-Clark, S
    Willems, HMG
    Williams, A
    Harris, W
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2006, 46 (02) : 642 - 647
  • [50] Structure-based design and synthesis of tyrosine-based PPAR-γ agonists.
    Liu, KG
    Lambert, MH
    Ayscue, AH
    Henke, BR
    Leesnitzer, LM
    Oliver, W
    Plunket, KD
    Xu, HE
    Sternbach, DD
    Willson, TM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U667 - U667
12345